High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalA conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma CareEMT, CTCs and CSCs in tumor relapse and drug-resistanceChemotherapy targeting cancer stem cellsChemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsA novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cellsEnhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.Latest progress in tyrosine kinase inhibitorsCytotoxic Indole Alkaloid 3α-Acetonyltabersonine Induces Glioblastoma Apoptosis via Inhibition of DNA Damage Repair.ABC transporters in CSCs membranes as a novel target for treating tumor relapse.Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo.Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features.Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells.Getting to the source: selective drug targeting of cancer stem cells.Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactionsDisulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells.Emerging targets for glioblastoma stem cell therapyDisulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.Scalable Production of Glioblastoma Tumor-initiating Cells in 3 Dimension Thermoreversible Hydrogels.Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells.PCM1 Depletion Inhibits Glioblastoma Cell Ciliogenesis and Increases Cell Death and Sensitivity to Temozolomide.High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factorsDisulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells.New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells.Glioma stem cells: turpis omen in nomen? (The evil in the name?).Apigenin Inhibits Cancer Stem Cell-Like Phenotypes in Human Glioblastoma Cells via Suppression of c-Met Signaling.Toward precision medicine in glioblastoma: the promise and the challenges.Existing drugs and their application in drug discovery targeting cancer stem cells.Anti-Tumor Effects of Cardiac Glycosides on Human Lung Cancer Cells and Lung Tumorspheres.Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing.Disruption of KIF3A in patient-derived glioblastoma cells: effects on ciliogenesis, hedgehog sensitivity, and tumorigenesis.Cytotoxic constituents of Abutilon indicum leaves against U87MG human glioblastoma cells.
P2860
Q26744536-10D547E0-BB60-4254-8518-193DD1314BA4Q26851160-B7980DB4-F512-41F2-B398-3EE4150DF0E6Q28082935-EB170839-BA94-418F-B97C-D286E9002E03Q28085377-C751E818-C1A9-4AE8-8BA2-B19B315728DBQ28547244-793A021D-997B-423E-B79C-D4B0EC2D62B9Q28817916-DBD0F3A7-EF72-4ED6-B8C4-C3AAC76F7CE1Q30452421-7D4D4FF8-EF6E-49A1-A2F9-E80915C6D88FQ33576849-C0A3FD1B-6A6D-4E4C-8382-DC031E88BB48Q33744717-32651C51-1503-4094-9A47-750DF5121996Q33879326-7618E680-6759-4D27-9453-3894919D8575Q34365729-C78EE33F-1C6B-46A4-A6F8-E15F358F8A67Q34474583-C7C5EE08-E7E1-42B5-AE8D-3798CD36AB2FQ34619336-5D5A3514-1700-4884-ADB0-2051DA69514FQ34652107-91D98ED1-BC10-44DB-92E4-C79763E8D2DAQ35156404-F0D8D63C-337F-49E2-A014-2BEDB36C745DQ35542866-5D0BC6C8-F9D7-4FAB-BC7E-8EE37CEB85EBQ35741690-B06B6AE5-A296-450D-876F-2418B86307A0Q35749822-AD03D467-2676-4250-B9BD-42001D7038EDQ35788952-2E44909D-DCBB-4E24-86FE-3DA329A1B498Q35794896-E76AD1B2-E472-4DFC-9919-B62FB7ED02AAQ36231919-753498A1-D138-4133-9CF5-80F8106D65A9Q36502009-CE23E8EE-9E07-47FF-BA1A-6333B29BC0F1Q36557426-A6FC7237-629B-4E7F-901E-FD1BD02D68AFQ36562209-AB1A6680-D462-4A4A-AE73-BB3DFC9B345BQ36654402-6864F957-3626-4756-9782-325946C6D817Q37195569-DE62D083-9FED-46E7-9DEC-4E3D242BE244Q37214346-6B2AB52C-F236-48F1-AC37-DA24AFA99A59Q37280484-2DA612A6-D7D2-4FB0-A00D-F92FBE3907B1Q37420053-7D3C3335-9A67-4A19-BE86-0B1B4438A4FDQ37616054-91D5367A-FD06-49C8-A2FC-AFAC8DAEE710Q37719254-E3DD4A1D-0957-4877-8034-81A0B505776AQ38187997-6D147479-5233-4A1F-A1BA-888D44A141A7Q38202702-39CBFA57-9CA7-4E85-8F07-6B3AFBE1FDB9Q38408987-605EFD0B-EE1D-478F-A7A5-0FEE3D78512CQ38454659-855509E4-BEF5-41A9-839A-CBEF417BB2B9Q38543730-15C64909-CFCC-4EB5-8ED3-D1BE83FD47D5Q38744132-94E8C265-B61D-4FA3-B530-784C79705DACQ38762476-046EC54C-BAC6-4254-A36A-4E700AD2C488Q38804205-277CFFEB-BA4B-45DE-873A-3D1757FD0DBAQ38938010-B14E3AC1-5C47-45F7-A289-AC763F0B5598
P2860
High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High-throughput chemical scree ...... human glioblastoma stem cells.
@ast
High-throughput chemical scree ...... human glioblastoma stem cells.
@en
High-throughput chemical scree ...... human glioblastoma stem cells.
@nl
type
label
High-throughput chemical scree ...... human glioblastoma stem cells.
@ast
High-throughput chemical scree ...... human glioblastoma stem cells.
@en
High-throughput chemical scree ...... human glioblastoma stem cells.
@nl
prefLabel
High-throughput chemical scree ...... human glioblastoma stem cells.
@ast
High-throughput chemical scree ...... human glioblastoma stem cells.
@en
High-throughput chemical scree ...... human glioblastoma stem cells.
@nl
P2093
P2860
P356
P1433
P1476
High-throughput chemical scree ...... human glioblastoma stem cells.
@en
P2093
Brent Reynolds
Greg Foltz
Jae-Geun Yoon
Liping Chen
Loic Deleyrolle
Parvinder Hothi
Timothy J Martins
P2860
P304
P356
10.18632/ONCOTARGET.707
P407
P577
2012-10-01T00:00:00Z